Novel roles of gastrin

Journal of Physiology

Volumn 592, Issue 14, 2014, Pages 2951-2958

  Dimaline, Rod ^a   Varro, Andrea ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARBOXY TERMINAL FLANKING PEPTIDE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHROMOGRANIN A; GASTRIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLYCINE; HISTAMINE; HISTIDINE DECARBOXYLASE; HORMONE RECEPTOR; INCRETIN; INTERLEUKIN 8; INTESTINAL TREFOIL FACTOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; NETAZEPIDE; PEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROGASTRIN; PROGASTRIN RECEPTOR; PROSTAGLANDIN E2; PROTON PUMP INHIBITOR; SERINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; ZP 3022;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; COLON MUCOSA; DNA MICROARRAY; ENTEROCHROMAFFIN LIKE CELL; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL CANCER CELL LINE; EXTRACELLULAR MATRIX; GASTRIN GENE; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE PRODUCT; GLYCEMIC CONTROL; HELICOBACTER INFECTION; HORMONE RELEASE; HUMAN; HYPERGASTRINEMIA; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH PARIETAL CELL; UPREGULATION; ANIMAL; METABOLISM; PHYSIOLOGY; STOMACH; STOMACH TUMOR;

ANIMALS; GASTRINS; HUMANS; INCRETINS; RECEPTOR, CHOLECYSTOKININ B; STOMACH; STOMACH NEOPLASMS;

EID: 84904335171     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.272435     Document Type: Article

References (69)

1. Almeida-Vega S, Catlow K, Kenny S, Dimaline R & Varro A (2009). Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1. Am J Physiol Gastrointest Liver Physiol 296, G414-423.
2. Beales IL (2013). Glycine-extended gastrin enhances somatostatin release from cultured rabbit fundic D-cells. F1000Research 2, 56.
3. Beales IL & Ogunwobi OO (2009). Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation. J Mol Endocrinol 42, 305-318.
4. Bertrand C, Kowalski-Chauvel A, Do C, Resa C, Najib S, Daulhac L, Wang TC, Ferrand A & Seva C (2010). A gastrin precursor, gastrin-gly, upregulates VEGF expression in colonic epithelial cells through an HIF-1-independent mechanism. Int J Cancer 126, 2847-2857.
5. Bishop L, Dimaline R, Blackmore C, Deavall D, Dockray GJ & Varro A (1998). Modulation of the cleavage of the gastrin precursor by phosphorylation. Gastroenterology 115, 1154-1162.
6. Bodger K, Ahmed S, Pazmany L, Pritchard DM, Micheal A, Khan AL, Dimaline R, Dockray GJ & Varro A (2008). Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection. J Clin Pathol 61, 72-78.
7. Bramante G, Patel O, Shulkes A & Baldwin GS (2011). Ferric ions inhibit proteolytic processing of progastrin. Biochem Biophys Res Commun 404, 1083-1087.
8. Brand SJ & Fuller PJ (1988). Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 263, 5341-5347.
9. Burkitt MD, Varro A & Pritchard DM (2009). Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 15, 1-16.
10. Clarke PA, Dickson JH, Harris JC, Grabowska A & Watson SA (2006). Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res 66, 3504-3512.
11. Dimaline R & Varro A (2007). Attack and defence in the gastric epithelium - a delicate balance. Exp Physiol 92, 591-601.
12. Dockray G, Dimaline R & Varro A (2005). Gastrin: old hormone, new functions. Pflugers Arch 449, 344-355.
13. Dockray GJ, Moore A, Varro A & Pritchard DM (2012). Gastrin receptor pharmacology. Curr Gastroenterol Rep 14, 453-459.
14. Dockray GJ, Varro A, Dimaline R & Wang T (2001). The gastrins: their production and biological activities. Annu Rev Physiol 63, 119-139.
15. Dubeykovskiy A, Nguyen T, Dubeykovskaya Z, Lei S & Wang TC (2008). Flow cytometric detection of progastrin interaction with gastrointestinal cells. Regul Peptides 151, 106-114.
16. Duckworth CA, Clyde D, Worthley DL, Wang TC, Varro A & Pritchard DM (2013). Progastrin-induced secretion of insulin-like growth factor 2 from colonic myofibroblasts stimulates colonic epithelial proliferation in mice. Gastroenterology 145, 197-208.
17. Edkins JS (1905). On the chemical mechanism of gastric secretion. Proc Roy Soc Ser B 76, 376-376.
18. Ferrand A, Lachal S, Bramante G, Kovac S, Shulkes A & Baldwin GS (2010). Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine. Am J Physiol Gastrointest Liver Physiol 299, G220-G227.
19. Ferrand A, Sandrin MS, Shulkes A & Baldwin GS (2009). Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth. Biochim Biophys Acta 1793, 477-488.
20. Ferrand A & Wang TC (2006). Gastrin and cancer: a review. Cancer Lett 238, 15-29.
21. Fjeldbo CS, Bakke I, Erlandsen SE, Holmseth J, Laegreid A, Sandvik AK, Thommesen L & Bruland T (2012). Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. Am J Physiol Gastrointest Liver Physiol 302, G21-G33.
22. Fosgerau K, Jessen L, Lind Tolborg J, Osterlund T, Schaeffer Larsen K, Rolsted K, Brorson M, Jelsing J & Skovlund Ryge Neerup T (2013). The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice. Diabetes Obes Metabol 15, 62-71.
23. Fossmark R, Sordal O, Jianu CS, Qvigstad G, Nordrum IS, Boyce M & Waldum HL (2012). Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther 36, 1067-1075.
24. Franic TV, van Driel IR, Gleeson PA, Giraud AS & Judd LM (2005). Reciprocal changes in trefoil 1 and 2 expression in stomachs of mice with gastric unit hypertrophy and inflammation. J Pathol 207, 43-52.
25. Goetze JP, Eiland, S, Svendsen LB, Vainer B, Hannibal J & Rehfeld JF (2013). Characterization of gastrins and their receptor in solid human gastric adenocarcinomas. Scand J Gastroenterol 48, 688-695.
26. Gregory RA & Tracy HJ (1964). The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 5, 103-114.
27. Gregory RA (1974). The Bayliss-Starling lecture 1973. The gastrointestinal hormones: a review of recent advances. J Physiol 241, 1-32.
28. Grossman MI, Robertson CR & Ivy AC (1948). The proof of a hormonal mechanism for gastric secretion - the humoral transmission of the distension stimulus. Am J Physiol 153, 1-9.
29. Haigh CR, Atwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, Varro A & Dimaline R (2003). Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 124, 615-625.
30. Hove KD, Brons C, Faerch K, Lund SS, Petersen JS, Karlsen AE, Rossing P, Rehfeld JF & Vaag A (2013). Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study. Diabetologia 56, 22-30.
31. Jain RN & Samuelson LC (2007). Transcriptional profiling of gastrin-regulated genes in mouse stomach. Physiol Genomics 29, 1-12.
32. Jin G, Ramanathan V, Quante M, Baik GH, Yang X, Wang SS, Tu S, Gordon SA, Pritchard DM, Varro A, Shulkes A & Wang TC (2009). Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J Clin Invest 119, 2691-2701.
33. Jin G, Westphalen CB, Hayakawa Y, Worthley DL, Asfaha S, Yang X, Chen X, Si Y, Wang H, Tailor Y, Friedman RA & Wang TC (2013). Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2. Gastroenterology 145, 820-830.
34. Khan ZE, Wang TC, Cui G, Chi AL & Dimaline R (2003). Transcriptional regulation of the human trefoil factor, TFF1, by gastrin. Gastroenterology 125, 510-521.
35. Koh TJ, Field JK, Varro A, Liloglou T, Fielding P, Cui G, Houghton J, Dockray GJ & Wang TC (2004). Glycine-extended gastrin promotes the growth of lung cancer. Cancer Res 64, 196-201.
36. Kowalski-Chauvel A, Najib S, Tikhonova IG, Huc L, Lopez F, Martinez LO, Cohen-Jonathan-Moyal E, Ferrand A & Seva C (2012). Identification of the F1-ATPase at the cell surface of colonic epithelial cells: role in mediating cell proliferation. J Biol Chem 287, 41458-41468.
37. Larsson LI, Rehfeld JF, Sundkler F & Håkanson R (1976). Pancreatic gastrin in foetal and neonatal rats. Nature 262, 609-610.
38. Marshall KM, Patel O, Bramante G, Laval M, Yim M, Baldwin GS & Shulkes A (2013). The C-terminal flanking peptide of progastrin induces gastric cell apoptosis and stimulates colonic cell division in vivo. Peptides 46, 83-93.
39. Misund K, Selvik LK, Rao S, Norsett K, Bakke I, Sandvik AK, Laegreid A, Bruland T, Prestvik WS & Thommesen L (2013). NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells. PloS ONE 8, e76234.
40. Miyazaki Y, Shinomura Y, Tsutsui S, Zushi S, Higashimoto Y, Kanayama S, Higashiyama S, Taniguchi N & Matsuzawa Y (1999). Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor. Gastroenterology 116, 78-89.
41. Moore AR, Boyce M, Steele IA, Campbell F, Varro A & Pritchard DM (2013). Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis. PloS ONE 8, e76462.
42. Norsett KG, Laegreid A, Kusnierczyk W, Langaas M, Ylving S, Fossmark R, Myhre S, Falkmer S, Waldum HL & Sandvik AK (2008). Changes in gene expression of gastric mucosa during therapeutic acid inhibition. Eur J Gastroenterol Hepatol 20, 613-623.
43. Norsett KG, Laegreid A, Langaas M, Worlund S, Fossmark R, Waldum HL & Sandvik AK (2005). Molecular characterization of rat gastric mucosal response to potent acid inhibition. Physiol Genomics 22, 24-32.
44. Norsett KG, Steele I, Duval C, Sammut SJ, Murugesan SV, Kenny S, Rainbow L, Dimaline R, Dockray GJ, Pritchard DM & Varro A (2011). Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 301, G446-453.
45. O'Hara A, Howarth A, Varro A & Dimaline R (2013). The role of proteasome beta subunits in gastrin-mediated transcription of plasminogen activator inhibitor-2 and regenerating protein1. PloS One 8, e59913.
46. Ogunwobi OO & Beales IL (2008). Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-κB activation in Barrett's oesophageal adenocarcinoma cells. Mol Cell Endocrinol 296, 94-102.
47. Pagliocca A, Hegyi P, Venglovecz V, Rackstraw SA, Khan ZE, Burdyga G, Wang TC, Dimaline R, Varro A & Dockray GJ (2008). Identification of ezrin as a target of gastrin in immature mouse gastric parietal cells. Exp Physiol 93, 1174-1189.
48. Pannequin J, Bonnans C, Delaunay N, Ryan J, Bourgaux JF, Joubert D & Hollande F (2009). The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells. Cancer Res 69, 6065-6073.
49. Patel O, Marshall KM, Bramante G, Baldwin GS & Shulkes A (2010). The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway. Regul Pept 165, 224-231.
50. Ramanathan V, Jin G, Westphalen CB, Whelan A, Dubeykovskiy A, Takaishi S & Wang TC (2012). P53 gene mutation increases progastrin dependent colonic proliferation and colon cancer formation in mice. Cancer Invest 30, 275-286.
51. Rehfeld JF & Stadil F (1973). The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest 52, 1415-1426.
52. Sadry SA & Drucker DJ (2013). Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol 9, 425-433.
53. Sarkar S, Kantara C, Ortiz I, Swiercz R, Kuo J, Davey R, Escobar K, Ullrich R & Singh P (2012a). Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells. Int J Cancer 131, E1088-1099.
54. Sarkar S, Kantara C & Singh P (2012b). Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2. Am J Physiol Gastrointest Liver Physiol 302, G712-722.
55. Seva C, Dickinson CJ & Yamada T (1994). Growth-promoting effects of glycine-extended progastrin. Science 265, 410-412.
56. Sinclair NF, Ai W, Raychowdhury R, Bi M, Wang TC, Koh TJ & McLaughlin JT (2004). Gastrin regulates the heparin binding epidermal-like growth factor promoter via a PKC/EGFR dependent mechanism. Am J Physiol Gastrointest Liver Physiol 286, G992-999.
57. Singh PK, Hota D, Dutta P, Sachdeva N, Chakrabarti A, Srinivasan A, Singh I & Bhansali A (2012). Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 97, E2105-2108.
58. Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M & Rabinovitch A (2008). Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57, 3281-3288.
59. Tu S, Chi AL, Lim S, Cui G, Dubeykovskaya Z, Ai W, Fleming JV, Takaishi S & Wang TC (2007). Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol 292, G1726-1737.
60. Umar S, Sarkar S, Cowey S & Singh P (2008). Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo. Oncogene 27, 5599-5611.
61. Umar S, Sarkar S, Wang Y & Singh P (2009). Functional cross-talk between β-catenin and NFκB signaling pathways in colonic crypts of mice in response to progastrin. J Biol Chem 284, 22274-22284.
62. Unger RH, Ketterer H, Dupre J & Eisentraut AM (1967). The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest 46, 630-645.
63. Varro A, Hemers E, Archer D, Pagliocca A, Haigh C, Ahmed S, Dimaline R & Dockray GJ (2002). Identification of plasminogen activator inhibitor-2 as a gastrin- regulated gene: role of Rho GTPase and menin. Gastroenterology 123, 271-280.
64. Varro A, Kenny S, Hemers E, McCaig C, Przemeck S, Wang TC, Bodger K & Pritchard DM (2007). Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling. Am J Physiol Gastrointest Liver Physiol 292, 1133-1140.
65. Varro A, Noble PJ, Pritchard DM, Kennedy S, Hart CA, Dimaline R & Dockray GJ (2004). Helicobacter pylori induces plasminogen activator inhibitor 2 (PAI-2) in gastric epithelial cells through NF-kB and RhoA: implications for invasion and apoptosis. Cancer Res 64, 1695-1702.
66. Wang TC, Bonner-Weir S, Oates PS, Chulak MB, Simon B, Merlino GT, Schmidt EV & Brand SJ (1993). Pancreatic secretion stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells. J Clin Investigat 92, 1349-1356.
67. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ & Fox JG (2000). Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118, 36-47.
68. Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, Argent RH, Tobias A, Kumari R, Atherton JC & Watson SA (2010). Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 59, 1037-1045.
69. Yuan A, Liu J, Liu Y, Bjornsen T, Varro A & Cui G (2008). Immunohistochemical examination of gastrin, gastrin precursors, and gastrin/CCK-2 receptor in human esophageal squamous cell carcinomas. Pathol Oncol Res 14, 449-455.